Onyx Pharmaceuticals, Inc. And Bayer AG's Nexavar With Chemotherapy Slows Breast Cancer

Bookmark and Share

Dec. 11 (Bloomberg) -- Onyx Pharmaceuticals Inc. and Bayer AG said their Nexavar pill, approved for liver and kidney tumors, extended the lives of women with advanced breast cancer by delaying growth of malignancies that had spread or recurred.

Back to news